You have 9 free searches left this month | for more free features.

Sarcoma, Synovial

Showing 1 - 25 of 1,545

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Synovial Sarcoma Trial in Philadelphia

Recruiting
  • Synovial Sarcoma
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Jun 21, 2023

    Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)

    Recruiting
    • Ewing Sarcoma
    • +2 more
    • Peptide vaccine IPX
    • Frankfurt am Main, Germany
    • +2 more
    Oct 18, 2023

    Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)

    Not yet recruiting
    • Synovial Sarcoma
    • Fludarabine phosphate
    • +2 more
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 9, 2023

    Tumors Trial in Worldwide (Letetresgene autoleucel)

    Active, not recruiting
    • Neoplasms
    • Letetresgene autoleucel
    • Pittsburgh, Pennsylvania
    • +5 more
    Aug 7, 2023

    Synovial Sarcoma, Soft Tissue Sarcoma Trial in United States (CFT8634)

    Recruiting
    • Synovial Sarcoma
    • Soft Tissue Sarcoma
    • Duarte, California
    • +12 more
    Feb 2, 2023

    Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

    Recruiting
    • Metastatic Leiomyosarcoma
    • +17 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 13, 2022

    Breast Cancer Metastatic, Pancreatic Cancer, NSCLC, Metastatic Trial in Denver, Grand Rapids (ST316)

    Not yet recruiting
    • Breast Cancer Metastatic
    • +7 more
    • Denver, Colorado
    • +1 more
    Apr 28, 2023

    Advanced Synovial Sarcoma Trial in Worldwide (FHD-609)

    Recruiting
    • Advanced Synovial Sarcoma
    • Duarte, California
    • +11 more
    Jul 29, 2022

    Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )

    Active, not recruiting
    • Alveolar Soft Part Sarcoma
    • +3 more
    • Phoenix, Arizona
    • +22 more
    Nov 1, 2022

    Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma, Epithelioid Sarcoma Trial in Bordeaux (Trabectedin)

    Recruiting
    • Soft Tissue Sarcoma Adult
    • +6 more
    • Bordeaux, France
      Institut Bergonie
    Feb 1, 2022

    Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma Trial in United States (Afamitresgene

    Not yet recruiting
    • Synovial Sarcoma
    • +3 more
    • Afamitresgene autoleucel
    • Palo Alto, California
    • +3 more
    Dec 6, 2022

    Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

    Temporarily not available
    • Epithelioid Sarcoma (Ex-US Only)
    • +19 more
    • (no location specified)
    Oct 17, 2022

    Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

    Terminated
    • Neoplasms
    • New Haven, Connecticut
    • +20 more
    Jul 5, 2023

    Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

    Active, not recruiting
    • Advanced Soft Tissue Sarcoma
    • +26 more
    • Doxorubicin Hydrochloride
    • +3 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jan 6, 2023

    Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

    Terminated
    • Neoplasms
    • New Haven, Connecticut
    • +20 more
    Sep 15, 2023

    Synovial Sarcoma, Myxoid Liposarcoma Trial in Worldwide (afamitresgene autoleucel (previously ADP-A2M4))

    Recruiting
    • Synovial Sarcoma
    • Myxoid Liposarcoma
    • afamitresgene autoleucel (previously ADP-A2M4)
    • Duarte, California
    • +26 more
    Dec 7, 2022

    Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,

    Recruiting
    • Sarcoma, Synovial
    • +8 more
    • CYCLOPHOSPHAMIDE and FLUDARABIN
    • +3 more
    • Jerusalem, Israel
      Hadassah Medical Organization
    Mar 15, 2022

    Synovial Sarcoma Trial in New York (ipilimumab)

    Terminated
    • Synovial Sarcoma
    • ipilimumab
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Jun 23, 2021

    Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

    Active, not recruiting
    • Malignant Rhabdoid Tumors (MRT)
    • +10 more
    • San Francisco, California
    • +31 more
    Jan 17, 2023

    Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

    Withdrawn
    • Soft Tissue Sarcoma
    • +12 more
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2021

    Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • second generation 4-1BBζ EGFR806-EGFRt
    • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
    • Seattle, Washington
      Seattle Children's Hospital
    May 2, 2022

    Ewing Sarcoma, Myxoid/Round Cell Liposarcoma, Synovial Sarcoma Trial in United States (PRT2527)

    Recruiting
    • Ewing Sarcoma
    • +7 more
    • Denver, Colorado
    • +5 more
    Jun 9, 2022

    Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon

    Active, not recruiting
    • Metastatic Myxoid Liposarcoma
    • +15 more
    • Interferon Gamma-1b
    • +2 more
    • Palo Alto, California
    • +6 more
    Aug 2, 2022

    Synovial Sarcoma, Single or Multiple Lung Metastases Trial in United States (Whole Lung IMRT)

    Completed
    • Synovial Sarcoma
    • Single or Multiple Lung Metastases
    • Whole Lung IMRT
    • Basking Ridge, New Jersey
    • +4 more
    Jun 7, 2021

    Urinary Bladder Cancer, Melanoma, Head Neck Cancer Trial in Canada, United States (Autologous genetically modified MAGE-A4?¹º³²T

    Active, not recruiting
    • Urinary Bladder Cancer
    • +9 more
    • Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
    • Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
    • Miami, Florida
    • +10 more
    Aug 9, 2022